Joshua Higa | executive |
Emil Kakkis | executive |
Erik Harris | executive |
Howard Horn | executive |
Eric Crombez | executive |
Huidong Wang | analyst |
Salveen Richter | analyst |
Dae Gon Ha | analyst |
Tazeen Ahmad | analyst |
Kristen Kluska | analyst |
Priyanka Grover | analyst |
Joon Lee | analyst |
Maurice Raycroft | analyst |
Will Soghikian | analyst |
Yaron Werber | analyst |
Michael Riad | analyst |
Jack Allen | analyst |
Thank you.
We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com.
Joining me on this call are Emil Kakkis, Chief Executive Officer and President; Erik Harris, Chief Commercial Officer; Howard Horn, Chief Financial Service; and Eric Crombez, Chief Medical Officer. I'd like to remind everyone that during today's call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please refer to the risk factors discussed in our latest SEC filings. I'll now turn the call over to Emil.